Heparan sulfate proteoglycans in amyloidosis (Q37784314)

23 August 2017

title

Heparan sulfate proteoglycans in amyloidosis (English)

1 reference

heparan sulfate proteoglycans

23 August 2017

main subject

1 reference

Xiao Zhang

1

1 reference

23 August 2017

Jin-Ping Li

series ordinal

2

1 reference

23 August 2017

publication date

1 January 2010

1 reference

Progress in Molecular Biology and Translational Science

23 August 2017

published in

1 reference

23 August 2017

volume

93

1 reference

23 August 2017

page(s)

309-334

1 reference

Amyloid: toward terminology clarification. Report from the Nomenclature Committee of the International Society of Amyloidosis.

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Heparan sulphate proteoglycans in Alzheimer's disease and amyloid-related disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Functions of cell surface heparan sulfate proteoglycans

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Interactions between heparan sulfate and proteins-design and functional implications

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Heparan sulphate proteoglycans fine-tune mammalian physiology

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Amyloidosis: a convoluted story

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Amyloid peptides and proteins in review

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Electron Microscopic Observations on a Fibrous Component in Amyloid of Diverse Origins

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Review: history of the amyloid fibril

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

"Cross-beta" conformation in proteins.

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Protein misfolding, functional amyloid, and human disease

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Structural disorder in amyloid fibrils: its implication in dynamic interactions of proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Protein misfolding and neurodegeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

A primer of amyloid nomenclature

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

1 reference

7 January 2021

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

1 reference

7 January 2021

Amyloidosis: review and CT manifestations.

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

1 reference

7 January 2021

The systemic amyloidoses: clearer understanding of the molecular mechanisms offers hope for more effective therapies

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Amyloid precursors and amyloidosis in inflammatory arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Serum amyloid A (SAA): a concise review of biology, assay methods and clinical usefulness

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Expression and function of serum amyloid A, a major acute-phase protein, in normal and disease states

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Analytical evaluation of particle-enhanced immunonephelometric assays for C-reactive protein, serum amyloid A and mannose-binding protein in human serum

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Natural history and outcome in systemic AA amyloidosis

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Creation of "Amyloid" Fibrils from Bence Jones Proteins in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Amyloid fibril proteins: proof of homology with immunoglobulin light chains by sequence analyses

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Epidemiology and outcomes research for MGUS, myeloma and amyloidosis

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

1 reference

7 January 2021

Prevalence of germline mutations in the TTR gene in a consecutive series of surgical pathology specimens with ATTR amyloid.

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

The molecular biology and clinical features of amyloid neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Tabulation of human transthyretin (TTR) variants, 2003

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

A chemical approach to elucidate tin mechanism of transthyretin and β-protein amyloid fibril formation

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Examination of the Structure of the Transthyretin Amyloid Fibril by Image Reconstruction from Electron Micrographs

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Transthyretin and familial amyloidotic polyneuropathy. Recent progress in understanding the molecular mechanism of neurodegeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Amyloid deposits in transthyretin-derived amyloidosis: cleaved transthyretin is associated with distinct amyloid morphology.

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Frequency and distribution of senile cardiovascular amyloid. A clinicopathologic correlation

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Beta 2-microglobulin: a new form of amyloid protein associated with chronic hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Serum 2 -microglobulin in renal disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Serum beta2-microglobulin in hemodialyzed patients

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Beta 2-microglobulin associated amyloidosis: a vanishing complication of long-term hemodialysis?

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Increased binding of beta-2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced beta-2-microglobulin concentrations. Results of a cross-over study

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Quantitative studies on amyloid in the islets of Langerhans

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Islet amyloid: a critical entity in the pathogenesis of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

1 reference

7 January 2021

Mechanisms of tau-induced neurodegeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Alzheimer's disease and Down's syndrome: roles of APP, trophic factors and ACh.

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Chromosome 21 and down syndrome: from genomics to pathophysiology

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Novel proteinaceous infectious particles cause scrapie

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

1 reference

7 January 2021

Prion diseases and their biochemical mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Prions: protein aggregation and infectious diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Prion diseases of humans and animals: their causes and molecular basis

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Mammalian prion biology: one century of evolving concepts

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Heparin, heparan sulfate and heparanase in inflammatory reactions

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

The molecular diversity of glycosaminoglycans shapes animal development.

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Syndecans: multifunctional cell-surface co-receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Syndecans: transmembrane modulators of adhesion and matrix assembly

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

1 reference

7 January 2021

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

1 reference

7 January 2021

Glypicans: proteoglycans with a surprise

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Perlecan: how does one molecule do so many things?

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

New insights into the roles of agrin

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Perlecan--a multifunctional extracellular proteoglycan scaffold.

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Developmental expression of perlecan during murine embryogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Agrin is a heparan sulfate proteoglycan

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Basement membrane proteoglycans: from cellar to ceiling

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

A beta amyloidogenesis: unique, or variation on a systemic theme?

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Review: amyloidogenesis-unquestioned answers and unanswered questions

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Sulfated glycosaminoglycans in amyloid plaques of prion diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Sulfated glycosaminoglycans in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Presence of glycosaminoglycans in purified AA type amyloid fibrils associated with juvenile rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Isolation and characterization of the integral glycosaminoglycan constituents of human amyloid A and monoclonal light-chain amyloid fibrils.

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Interaction between circulating amyloid fibril protein precursors and extracellular tissue matrix components in the pathogenesis of systemic amyloidosis

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Glycosaminoglycans in extracts of cardiac amyloid fibrils from familial amyloid cardiomyopathy of Danish origin related to variant transthyretin Met 111.

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Ultrastructure of Familial Amyloid Polyneuropathy Amyloid Fibrils: Examination with High-Resolution Electron Microscopy

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Ultrastructural organization of hemodialysis-associated beta 2-microglobulin amyloid fibrils

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Islet amyloid formation associated with hyperglycemia in transgenic mice with pancreatic beta cell expression of human islet amyloid polypeptide.

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Islet amyloid: a long-recognized but underappreciated pathological feature of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Localization of amyloidogenic proteins and sulfated glycosaminoglycans in nontransmissible and transmissible cerebral amyloidoses

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Heparan sulfate proteoglycan is associated with amyloid plaques and neuroanatomically targeted PrP pathology throughout the incubation period of scrapie-infected mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

10E4 antigen of Scrapie lesions contains an unusual nonsulfated heparan motif

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Localization of heparan sulfate glycosaminoglycan and proteoglycan core protein in aged brain and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Microangiopathy and the colocalization of heparan sulfate proteoglycan with amyloid in senile plaques of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Cationic dyes reveal proteoglycans structurally integrated within the characteristic lesions of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Association of heparan sulfate proteoglycan with the neurofibrillary tangles of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Agrin in Alzheimer's disease: altered solubility and abnormal distribution within microvasculature and brain parenchyma

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Crucial role of heparan sulfate proteoglycan (agrin) in beta-amyloid formation in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Accumulation of heparan sulfate proteoglycans in cerebellar senile plaques.

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Heparan sulfate proteoglycan expression in cerebrovascular amyloid beta deposits in Alzheimer's disease and hereditary cerebral hemorrhage with amyloidosis (Dutch) brains.

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Agrin is a major heparan sulfate proteoglycan accumulating in Alzheimer's disease brain.

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Glypican-1 as an Abeta binding HSPG in the human brain: its localization in DIG domains and possible roles in the pathogenesis of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Distribution of A beta-associated proteins in cerebrovascular amyloid of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Microtubule-associated protein tau, heparan sulphate and alpha-synuclein in several neurodegenerative diseases with dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Sulfation of heparan sulfate associated with amyloid-beta plaques in patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Interactions of Alzheimer amyloid-beta peptides with glycosaminoglycans effects on fibril nucleation and growth

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

The sulfate moieties of glycosaminoglycans are critical for the enhancement of beta-amyloid protein fibril formation

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans.

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Heparin-induced conformational change in microtubule-associated protein Tau as detected by chemical cross-linking and phosphopeptide mapping

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Ligand binding promotes prion protein aggregation--role of the octapeptide repeats

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Glycosaminoglycans enhance the trifluoroethanol-induced extension of beta 2-microglobulin-related amyloid fibrils at a neutral pH.

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Heparin strongly enhances the formation of beta2-microglobulin amyloid fibrils in the presence of type I collagen

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Proteoglycans in the pathogenesis of Alzheimer's disease and other amyloidoses

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Common binding sites for beta-amyloid fibrils and fibroblast growth factor-2 in heparan sulfate from human cerebral cortex

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

pH-dependent binding of synthetic beta-amyloid peptides to glycosaminoglycans

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

The HHQK domain of beta-amyloid provides a structural basis for the immunopathology of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Sulfate content and specific glycosaminoglycan backbone of perlecan are critical for perlecan's enhancement of islet amyloid polypeptide (amylin) fibril formation

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Identification of a heparin binding domain in the N-terminal cleavage site of pro-islet amyloid polypeptide. Implications for islet amyloid formation

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Characterization of the Heparin Binding Site in the N-Terminus of Human Pro-Islet Amyloid Polypeptide: Implications for Amyloid Formation†

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Aberrant processing of human proislet amyloid polypeptide results in increased amyloid formation

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Proteoglycans synthesized and secreted by pancreatic islet beta-cells bind amylin

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Inhibition of glycosaminoglycan synthesis and protein glycosylation with WAS-406 and azaserine result in reduced islet amyloid formation in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

The heparin/heparan sulfate-binding site on apo-serum amyloid A. Implications for the therapeutic intervention of amyloidosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Amyloidogenesis recapitulated in cell culture: a peptide inhibitor provides direct evidence for the role of heparan sulfate and suggests a new treatment strategy

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Novel glycosaminoglycan precursors as antiamyloid agents: Part IV.

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Amyloid-specific heparan sulfate from human liver and spleen

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Molecular interactions in the formation and deposition of beta2-microglobulin-related amyloid fibrils

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Amyloid precursor protein trafficking, processing, and function

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Function, regulation and therapeutic properties of beta-secretase (BACE1).

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Spotlight on BACE: the secretases as targets for treatment in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Partial reduction of BACE1 has dramatic effects on Alzheimer plaque and synaptic pathology in APP Transgenic Mice

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Heparin promotes beta-secretase cleavage of the Alzheimer's amyloid precursor protein

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Heparan sulfate regulates amyloid precursor protein processing by BACE1, the Alzheimer's beta-secretase

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Heparin derivatives as inhibitors of BACE-1, the Alzheimer's beta-secretase, with reduced activity against factor Xa and other proteases.

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Engineered heparins: novel beta-secretase inhibitors as potential Alzheimer's disease therapeutics

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Effect of heparin on APP metabolism and Abeta production in cortical neurons

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Amyloid formation by pro-islet amyloid polypeptide processing intermediates: examination of the role of protein heparan sulfate interactions and implications for islet amyloid formation in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Glypican-1 mediates both prion protein lipid raft association and disease isoform formation

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

An important role of heparan sulfate proteoglycan (Perlecan) in a model system for the deposition and persistence of fibrillar A beta-amyloid in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Overproduction of perlecan core protein in cultured cells and transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Peripheral treatment with enoxaparin, a low molecular weight heparin, reduces plaques and beta-amyloid accumulation in a mouse model of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Inhibition of amyloidosis using low-molecular-weight heparins

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Transgenic expression of mammalian heparanase uncovers physiological functions of heparan sulfate in tissue morphogenesis, vascularization, and feeding behavior

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Substrate specificity of heparanases from human hepatoma and platelets

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

In vivo fragmentation of heparan sulfate by heparanase overexpression renders mice resistant to amyloid protein A amyloidosis

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Characterization of proteoglycans and glycosaminoglycans in bovine renal AA-type amyloidosis

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Heparan sulfate mediates amyloid-beta internalization and cytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

Corpora-amylacea and the family of polyglucosan diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

A review of early concepts of amyloid in context with contemporary chemical literature from 1839 to 1859.

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993013-5

7 January 2021

10.1016/S1877-1173(10)93013-5

Identifiers

DOI

1 reference

23 August 2017

1 reference